Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RARE
RARE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RARE News
A Doctor's Journey with His Son's Rare Disease
Apr 09 2026
CNBC
Ultragenyx Faces Class Action Lawsuit Over Stock Losses
Apr 06 2026
Globenewswire
Class Action Lawsuit Reminder Against Ultragenyx Pharmaceutical Inc.
Apr 06 2026
Globenewswire
Ultragenyx Pharmaceutical Class Action Notice
Apr 05 2026
Globenewswire
Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical Inc.
Apr 05 2026
Globenewswire
Ultragenyx Pharmaceutical Class Action Reminder
Apr 04 2026
PRnewswire
Faruqi & Faruqi Encourages Ultragenyx Investors to Reach Out
Apr 04 2026
PRnewswire
Ultragenyx Pharmaceutical Faces Class Action Lawsuit
Apr 03 2026
PRnewswire
Ultragenyx Securities Class Action Reminder
Apr 02 2026
Globenewswire
Ultragenyx's Gene Therapy Application Accepted by FDA
Apr 02 2026
seekingalpha
Ultragenyx Seeks Accelerated Approval for UX111 Gene Therapy
Apr 02 2026
NASDAQ.COM
UX111 Poised to Be First Therapy for Sanfilippo Syndrome Type A
Apr 02 2026
Newsfilter
Ultragenyx Pharmaceutical Faces Class Action Lawsuit
Apr 01 2026
Globenewswire
Ultragenyx Pharmaceutical Faces Class Action Lawsuit Over Securities Fraud
Apr 01 2026
Globenewswire
Reminder of Class Action Lawsuits Against Mereo BioPharma and Others
Mar 31 2026
Globenewswire
Ultragenyx Pharmaceutical Class Action Notice Issued
Mar 30 2026
PRnewswire
Show More News
